Back

Clonal hematopoiesis has prognostic value in dilated cardiomyopathy independent of age and clone size

21 May 2023 (16:08 - 16:17)
Organised by: Logo
Congress Presentation Part of: From bedside to bench and back Heart Failure with Reduced Ejection Fraction (HFrEF) HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Mr Maurits Sikking

Cardiovascular Research Institute Maastricht (CARIM), Maastricht (Netherlands (The))

6 More presentations in this session

Presentation thumbnail
Proteomic clusters of patients with new onset heart failure; more inflammation and worse prognosis in cluster with preserved ejection fraction - the PREFERS Study
Assistant Professor C. Hage (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Identification of risk and protective factors in titin cardiomyopathy
Miss S. Stroeks (Maastricht, NL)
Abstract Slides Video
Presentation thumbnail
Phospholamban antisense treatment attenuates hallmarks of disease in PLN R14del human iPSC derived cardiomyocytes
Mr F. Deiman (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
Defect in PKA-mediated proteasome activation is a key pathogenic factor for cardiac proteinopathy
Professor X. Wang (Vermillion, US)
Abstract Slides Video
Presentation thumbnail
ATPase inhibitory factor 1 (ATPIF-1) preserves cardiac function during ageing
Mr P. Sanchez (Groningen, NL)
Abstract Slides Video

Access the full session

Session thumbnail
From bedside to bench and back
Video

The Event

Event poster

Heart Failure 2023

21 May 2023 16:08 CET
You may be interested in
thumbnail
Congress Presentation
Clonal haematopoiesis
thumbnail
Congress Presentation
Clonal hematopoiesis: a novel approach to prevent heart failure
thumbnail
Congress Presentation
Somatic mutations and clonal haematopoiesis: biomarkers or mediators of cardiovascular ageing?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources